104 related articles for article (PubMed ID: 8452109)
1. Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group.
Chang A; Hunt M; Parkinson DR; Hochster H; Smith TJ
Am J Clin Oncol; 1993 Apr; 16(2):152-5. PubMed ID: 8452109
[TBL] [Abstract][Full Text] [Related]
2. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).
Hochster H; Hunt M; Green M; Parkinson D; Smith T
Invest New Drugs; 1990 Aug; 8(3):329-32. PubMed ID: 2272773
[TBL] [Abstract][Full Text] [Related]
3. Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium.
Hauke RJ; Infante JR; Rubin MS; Shih KC; Arrowsmith ER; Hainsworth JD
Melanoma Res; 2013 Dec; 23(6):468-73. PubMed ID: 23969699
[TBL] [Abstract][Full Text] [Related]
4. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies.
Lopez AM; Ketchum M; Nichols H; Xu MJ; Peng YM; Dorr R; Alberts DS
Cancer Chemother Pharmacol; 2000; 46(5):411-5. PubMed ID: 11127946
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.
Slavik M; Liu PY; Kraut EH; Natale RB; Flaherty LE; Sondak VK
Invest New Drugs; 1995; 13(2):143-7. PubMed ID: 8617577
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of carboplatin in advanced malignant melanoma.
Evans LM; Casper ES; Rosenbluth R
Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group Study.
Alberts DS; Mason-Liddil N; Green SJ; Cowan JD; Fletcher WS; Neilan B; Guy JT; Epstein RB
Invest New Drugs; 1987; 5(3):289-92. PubMed ID: 3667164
[TBL] [Abstract][Full Text] [Related]
10. Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.
Lee CK; Jung M; Choi HJ; Kim HR; Kim HS; Roh MR; Ahn JB; Chung HC; Heo SJ; Rha SY; Shin SJ
Cancer Res Treat; 2015 Oct; 47(4):781-9. PubMed ID: 25687848
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of carboplatin in patients with advanced melanoma.
Casper ES; Bajorin D
Invest New Drugs; 1990 May; 8(2):187-90. PubMed ID: 1696568
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.
Rosenthal MA; Green M; Wiernik P; Borden EC; Marsh JC; Haller DG
Am J Clin Oncol; 1998 Oct; 21(5):509-12. PubMed ID: 9781611
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
Pignata S; Scambia G; Savarese A; Breda E; Sorio R; Pisano C; Lorusso D; Cognetti F; Vernaglia Lombardi A; Gebbia V; Scollo P; Morabito A; Signoriello G; Perrone F
Oncology; 2009; 76(1):49-54. PubMed ID: 19039248
[TBL] [Abstract][Full Text] [Related]
15. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
16. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
Agarwala SS; Ferri W; Gooding W; Kirkwood JM
Cancer; 1999 May; 85(9):1979-84. PubMed ID: 10223239
[TBL] [Abstract][Full Text] [Related]
17. A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.
Smylie MG; Wong R; Mihalcioiu C; Lee C; Pouliot JF
Invest New Drugs; 2007 Apr; 25(2):155-9. PubMed ID: 16957835
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC).
Langer CJ; McAleer CA; Bonjo CA; Litwin S; Millenson M; Kosierowski R; Blankstein K; Alexander R; Ozols RF
Eur J Cancer; 2000 Jan; 36(2):183-93. PubMed ID: 10741276
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of epirubicin in advanced malignant melanoma.
Lopez M; Perno CF; Papaldo P; Di Lauro L; Ganzina F; Barduagni A
Invest New Drugs; 1984; 2(3):315-7. PubMed ID: 6595241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
